Solidus Biosciences provides data on drug patents, market opportunities, and competitive intelligence, supporting the lifecycle management of drugs from patent inception to expiration. The company serves sectors involved in drug development, patent analysis, and market strategy within the biopharmaceutical domain. It is based in Troy, New York.

Regene Med specializes in the development of engineered human tissue-based assays for the pharmaceutical industry. The company offers contract testing services and products that facilitate in vitro growth of human tissues for drug safety and efficacy evaluation, aiming to replace traditional cell-based assays and animal testing. Regene Med's technologies are utilized across various applications, including drug discovery, biosensors, diagnostics, medical devices, and tissue implants. It was founded in 2003 and is based in San Diego, California.

Ocimum Biosolutions is a company that offers life science informatics services within the biotechnology and pharmaceutical sectors. The company provides services including laboratory data management, genomics data analysis, bioinformatics, and genomics databases. Ocimum serves the pharmaceutical, biotech, and research institute sectors with its genomic services and informatics solutions. It was founded in 2000 and is based in Gaithersburg, Maryland.

The company's core business is and remains the development and production of Active Pharmaceutical Ingredient and parenteral formulations in the the form of solution and Lyophilized injection, in areas like anesthialogy and oncology.

Kiyatec operates in the healthcare and biotechnology sectors. They utilize living tumor cells to create functional 3D models for testing various treatments in their certified laboratories. Kiyatec collaborates with cancer hospitals, pharmaceutical companies, and the National Cancer Institute to validate its approach and is conducting clinical trials. It was founded in 2005 and is based in Greenville, South Carolina.

Rhenovia Pharma is a French biotech company that specializes in biosimulation technology within the neuroscience and pharmaceutical industries. The company provides computational models that replicate the brain's cellular and molecular mechanisms, allowing for the simulation of various nervous system conditions. Rhenovia's technology is used for predicting the efficacy and toxicity of drug candidates and for research and development partnerships focused on drug development processes. It is based in Mulhouse, France.